[1] 王兆钺,阮长耿. 血小板无力症治疗的现状和展望[J]. 中华血液学杂志,2016,37(5):430-431. Wang ZY,Ruan CG.Current state and prospect in treatment of Glanzmann's thrombasthenia[J]. Chin J Hematol,2016,37(5):430-431. [2] 甘芳宴,屈晨雪. 血小板无力症发病机制研究进展[J]. 临床检验杂志,2019,37(9):686-690. Gan FY,Qu CX.Advances in the pathogenesis of thrombocytopenic asthenia[J]. Chin J Clin Lab Sci,2019,37(9):686-690. [3] Gresele P,andSubcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders:guidance from the SSC of the ISTH[J]. J Thromb Haemost,2015,13(2):314-322. [4] Ribeiro ÂM,Zepeda-Mendoza ML,Bertelsen MF,et al.A refined model of the genomic basis for phenotypic variation in vertebrate hemostasis[J]. BMC Evol Biol,2015,15:124. [5] 袁洪波,张伶俐,杨春松. 儿童患者环孢素治疗药物监测必要性的系统评价[J]. 中国医院用药评价与分析,2018,18(3):300-304. Yuan HB,Zhang LL,Yang CS.Systematic review on the necessity of therapeutic drug monitoring of cyclosporin A on child patients[J]. Eval Anal Drug Use Hosp China,2018,18(3):300-304. [6] 陈秀萍,费玲,杨雯洁,等. 智能药盒的设计和应用[J]. 护理与康复,2021,20(8):98-99. Chen XP,Fei L,Yang WJ,et al.Design and application of intelligent medicine box[J]. J Nurs Rehabil,2021,20(8):98-99. |